Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

APYXAPYX
26 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in APYX MEDICAL CORPORATION

CITADEL ADVISORS LLC holds 168,344 shares of APYX (APYX MEDICAL CORPORATION), worth $755,864 as of 2026-Q2. The position was increased (+56.2% shares). APYX represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$755,864

Current Shares

168,344

Total Value Change

+$640,864

Total Shares Change

+150,143

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
168,344
+56.2%
$755,8640.0%$4.49
35
2026-Q1
New
107,798
-
$397,7750.0%$3.17
33
2025-Q4
Exited
0
-100.0%
$00.0%$3.44
0
2025-Q3
New
13,292
-
$28,4450.0%$2.18
30
2025-Q2
Exited
0
-100.0%
$00.0%$2.16
0
2025-Q1
Decreased
13,566
-79.6%
$18,5850.0%$1.30
0
2024-Q4
Increased
66,355
+427.8%
$104,8410.0%$1.58
24
2024-Q3
Increased
12,573
+283.8%
$15,5910.0%$1.20
20
2024-Q2
New
3,276
-
$4,3900.0%$1.34
22
2024-Q1
Exited
0
-100.0%
$00.0%$1.36
0
2023-Q4
Increased
59,785
+313.6%
$156,6370.0%$2.62
25
2023-Q3
Increased
14,456
+442.4%
$46,2590.0%$3.20
22
2023-Q2
Decreased
2,665
-97.7%
$13,4050.0%$6.70
0
2023-Q1
Increased
113,833
+51.3%
$327,8390.0%$2.72
33
2022-Q4
Increased
75,255
+371.1%
$176,0970.0%$2.34
25
2022-Q3
Decreased
15,976
-83.2%
$72,0000.0%$4.50
0
2022-Q2
New
95,132
-
$557,0000.0%$6.33
34
2022-Q1
Exited
0
-100.0%
$00.0%$6.54
0
2021-Q4
Decreased
32,044
-35.6%
$411,0000.0%$12.59
0
2021-Q3
Decreased
49,766
-20.9%
$689,0000.0%$13.96
0
2021-Q2
Increased
62,904
+201.9%
$649,0000.0%$10.30
39
2021-Q1
New
20,833
-
$202,0000.0%$9.88
35
2020-Q2
Exited
0
-100.0%
$00.0%$5.30
0
2020-Q1
New
20,875
-
$75,0000.0%$3.57
33
2019-Q2
Exited
0
-100.0%
$00.0%$6.72
0
2019-Q1
New
18,201
-
$115,0000.0%$6.31
30

Other major holders of APYX: Steward Partners Investment Advisory, LLC, BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used